[ad_1] The experimental COVID-19 vaccine, developed by the University of Oxford, also triggers lower adverse responses among seniors and young adults, British drug maker AstraZeneca Plc, which is helping produce the vaccine, said Monday. “It is encouraging to see that immunogenicity responses were similar between older and younger adults and …
Read More »Coronavirus India lockdown Day 215 updates | AI will operate 260 Vande Bharat flights in 12 countries
